PROMINO NUTRITIONAL SCIENCES Financials Promino Nutritional Sciences Canadian Securities Exchange
Equities
MUSL
CA74290V1058
Food Processing
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.26 CAD | +8.33% |
|
-5.88% | +33.33% |
Valuation
| Fiscal Period: December | 2021 | 2022 | 2023 |
|---|---|---|---|
| Capitalization 1 | 42.01 | 8.997 | 7.541 |
| Enterprise Value (EV) 1 | 42.24 | 10.66 | 10.25 |
| P/E ratio | -4.14 x | -0.83 x | -1.19 x |
| Yield | - | - | - |
| Capitalization / Revenue | 17.8 x | 2.25 x | 15.8 x |
| EV / Revenue | 17.9 x | 2.66 x | 21.4 x |
| EV / EBITDA | -4.15 x | -1.03 x | -1.8 x |
| EV / FCF | -5,533,599 x | -13,023,223 x | -7,503,216 x |
| FCF Yield | -0% | -0% | -0% |
| Price to Book | 32.2 x | -1.85 x | -0.85 x |
| Nbr of stocks (in thousands) | 32,191 | 37,488 | 41,896 |
| Reference price 2 | 1.305 | 0.2400 | 0.1800 |
| Announcement Date | 02/05/22 | 15/06/23 | 07/05/24 |
1CAD in Million2CAD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 0.3717 | 1.674 | 0.9794 | 2.357 | 4.002 | 0.4782 |
| EBITDA 1 | -1.361 | -1.414 | -3.875 | -10.18 | -10.35 | -5.687 |
| EBIT 1 | -1.378 | -1.432 | -3.893 | -10.21 | -10.38 | -5.711 |
| Operating Margin | -370.83% | -85.51% | -397.46% | -433.35% | -259.45% | -1,194.3% |
| Earnings before Tax (EBT) 1 | -1.882 | -1.497 | -7.716 | -8.78 | -10.35 | -5.807 |
| Net income 1 | -1.882 | -1.497 | -7.716 | -8.78 | -10.35 | -5.807 |
| Net margin | -506.2% | -89.4% | -787.89% | -372.52% | -258.56% | -1,214.54% |
| EPS 2 | -0.4078 | -0.3244 | -1.078 | -0.3150 | -0.2901 | -0.1514 |
| Free Cash Flow | - | -1.025 | -0.1451 | -7.633 | -0.8187 | -1.366 |
| FCF margin | - | -61.2% | -14.82% | -323.88% | -20.46% | -285.65% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 22/01/21 | 22/01/21 | 25/05/21 | 02/05/22 | 15/06/23 | 07/05/24 |
1CAD in Million2CAD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 3.35 | 3.31 | 1.29 | 0.23 | 1.67 | 2.71 |
| Net Cash position 1 | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | -2.465 x | -2.338 x | -0.3317 x | -0.0226 x | -0.1609 x | -0.476 x |
| Free Cash Flow | - | -1.02 | -0.15 | -7.63 | -0.82 | -1.37 |
| ROE (net income / shareholders' equity) | - | 51% | 288% | 1,462% | 580% | 87.1% |
| ROA (Net income/ Total Assets) | - | -105% | -213% | -203% | -170% | -254% |
| Assets 1 | - | 1.419 | 3.622 | 4.33 | 6.097 | 2.287 |
| Book Value Per Share 2 | -1.010 | -0.9100 | -0.1300 | 0.0400 | -0.1300 | -0.2100 |
| Cash Flow per Share 2 | 0.0200 | 0.0200 | 0 | 0.0200 | 0 | 0 |
| Capex 1 | 0 | 0.02 | 0.01 | 0.04 | 0.02 | - |
| Capex / Sales | 0.39% | 1.46% | 1.02% | 1.58% | 0.58% | - |
| Announcement Date | 22/01/21 | 22/01/21 | 25/05/21 | 02/05/22 | 15/06/23 | 07/05/24 |
1CAD in Million2CAD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +16.80% | 8.33B | |
| +3.59% | 7.73B | |
| +15.02% | 6.83B | |
| -6.75% | 3.78B | |
| -4.09% | 3.76B | |
| +4.41% | 1.45B | |
| +20.28% | 1.05B | |
| -13.86% | 882M | |
| -15.47% | 778M |
- Stock Market
- Equities
- MUSL Stock
- MUSL Stock
- Financials Promino Nutritional Sciences
